ADCY2, adenylate cyclase 2, 108

N. diseases: 30; N. variants: 18
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.620 Biomarker disease CTD_human Genome-wide association study identifies 30 loci associated with bipolar disorder. 31043756 2019
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.620 GeneticVariation disease GWASCAT Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis. 27890468 2017
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.620 GeneticVariation disease BEFREE Interestingly, GWAS revealed an association between common ADCY2 variants and bipolar disorder, a disorder with considerable genetic overlap with schizophrenia. 25943950 2016
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.620 Biomarker disease BEFREE ADCY2 is a key enzyme in cAMP signalling and our finding provides new insights into the biological mechanisms involved in the development of BD. 24618891 2014
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.620 GeneticVariation disease GWASCAT ADCY2 is a key enzyme in cAMP signalling and our finding provides new insights into the biological mechanisms involved in the development of BD. 24618891 2014
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.620 GeneticVariation disease GWASDB ADCY2 is a key enzyme in cAMP signalling and our finding provides new insights into the biological mechanisms involved in the development of BD. 24618891 2014
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.620 Biomarker disease PSYGENET ADCY2 is a key enzyme in cAMP signalling and our finding provides new insights into the biological mechanisms involved in the development of BD. 24618891 2014
CUI: C0004096
Disease: Asthma
Asthma
0.310 Biomarker disease BEFREE Our results indicated that gene-environment interactions are important for asthma development and provided supportive evidence for interaction with air pollution for ADCY2, B4GALT5, and DLG2. 27901618 2017
CUI: C0004096
Disease: Asthma
Asthma
0.310 Biomarker disease CTD_human Identification of KIF3A as a novel candidate gene for childhood asthma using RNA expression and population allelic frequencies differences. 21912604 2011
CUI: C0005587
Disease: Depression, Bipolar
Depression, Bipolar
0.300 Biomarker disease CTD_human Genome-wide association study identifies 30 loci associated with bipolar disorder. 31043756 2019
CUI: C0024713
Disease: Manic Disorder
Manic Disorder
0.300 Biomarker disease CTD_human Genome-wide association study identifies 30 loci associated with bipolar disorder. 31043756 2019
CUI: C0338831
Disease: Manic
Manic
0.300 Biomarker disease CTD_human Genome-wide association study identifies 30 loci associated with bipolar disorder. 31043756 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 GeneticVariation group GWASCAT Genetic Variants Associated With Anxiety and Stress-Related Disorders: A Genome-Wide Association Study and Mouse-Model Study. 31116379 2019
CUI: C0021704
Disease: Intelligence
Intelligence
0.100 GeneticVariation phenotype GWASCAT Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. 29942086 2018
CUI: C0410702
Disease: Adolescent idiopathic scoliosis
Adolescent idiopathic scoliosis
0.100 GeneticVariation disease GWASCAT The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease. 30019117 2018
CUI: C0596887
Disease: mathematical ability
mathematical ability
0.100 GeneticVariation phenotype GWASCAT Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. 30038396 2018
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
0.100 GeneticVariation disease GWASCAT The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease. 30019117 2018
Attention deficit hyperactivity disorder
0.100 GeneticVariation disease GWASCAT Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis. 27890468 2017
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 GeneticVariation disease GWASCAT Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ1-42 Level. 26252872 2015
Low density lipoprotein cholesterol measurement
0.100 GeneticVariation phenotype GWASDB Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. 23063622 2012
CUI: C0428474
Disease: Serum LDL cholesterol measurement
Serum LDL cholesterol measurement
0.100 GeneticVariation phenotype GWASDB Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. 23063622 2012
CUI: C0428568
Disease: Fasting blood glucose measurement
Fasting blood glucose measurement
0.100 GeneticVariation phenotype GWASDB Variants in MTNR1B influence fasting glucose levels. 19060907 2009
CUI: C0206754
Disease: Neuroendocrine Tumors
Neuroendocrine Tumors
0.020 AlteredExpression group BEFREE Upregulation of AC2 is linked to cancers like pancreatic and small intestinal neuroendocrine tumors (NETs). 28068084 2017
CUI: C0206754
Disease: Neuroendocrine Tumors
Neuroendocrine Tumors
0.020 Biomarker group BEFREE Seven CREB response element (CRE) transcripts associated with proliferation and secretion: BEX1, BICD1, CHGB, CPE, GABRB3, SCG2 and SCG3 as well as ADCY2 and PRKAR1A were measured in an independent SI dataset (n = 10 NETs; n = 8 normal preparations). 21853033 2011
CUI: C4290046
Disease: trachomatis
trachomatis
0.020 Biomarker disease BEFREE In an analytical-method comparison study of clinical samples, the Abbott RealTime CT new formulation assay (m2000 real-time PCR), consisting of a duplex PCR targeting different parts of the cryptic plasmid in Chlamydia trachomatis, was compared both with version 2 of the Roche Cobas TaqMan CT assay, comprising a duplex PCR for a target in the cryptic plasmid and the omp1 gene, and with the Gen-Probe Aptima Combo 2 assay (AC2) targeting the C. trachomatis 23S rRNA molecule. 20007394 2010